Results 41 to 50 of about 1,268 (94)

Stereoselective, sex-dependent 5-HT_2A receptor modulation of cortical plasticity by MDMA in mice. [PDF]

Neuropsychopharmacology
Gaines-Smith MC, Silverman JM, Fiorillo M, Younkin J, Moore KN, Maltman JL, de la Fuente Revenga M, Wolstenholme JT, Glennon RA, Dukat M, González-Maeso J.   +10 more
europepmc   +1 more source

Toxicological evaluation, postmortem case descriptions, and pharmacological activity of N,N-dimethylpentylone and related analogs. [PDF]

J Anal Toxicol
Fogarty MF, Walton SE, Truver MT, Glatfelter GC, Krotulski AJ, Papsun DM, Lamb M, Chronister CW, Goldberger BA, Walther D, Barba K, Baumann MH, Logan BK.   +12 more
europepmc   +1 more source

Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities. [PDF]

Brain
Coray RC, Beliveau V, Zimmermann J, Preller KH, Wunderli M, Baumgartner MR, Seifritz E, Stock AK, Beste C, Cole DM, Quednow BB.   +10 more
europepmc   +1 more source

Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants. [PDF]

Neuropsychopharmacology
Straumann I, Vizeli P, Avedisian I, Erne L, Noorshams D, Vukalovic I, Eckert A, Luethi D, Rudin D, Liechti ME.   +9 more
europepmc   +1 more source

Rare but relevant: MDMA and hyponatraemia. [PDF]

Addiction
Garcia MR, Gomes NGM, Dias-da-Silva D.
europepmc   +1 more source

Synthesis, structure-activity relationships, and SARS-CoV-2 antiviral activity of 3,5-disubstituted isothiazolo[4,3-<i>b</i>]pyridines as PIKfyve inhibitors. [PDF]

Front Chem
Gao LJ, Kalebic D, Lo CW, Gangwal A, Tran DHN, Rozenski J, Schols D, Froeyen M, Dehaen W, Einav S, De Jonghe S.   +10 more
europepmc   +1 more source

Peer-led drug checking in Chile: a case study of the country's first harm reduction service at electronic music events. [PDF]

Harm Reduct J
Obregón-Berg C, Fuentealba-Donoso B, Vidal I, Navarrete J.   +3 more
europepmc   +1 more source

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants. [PDF]

Neuropsychopharmacology
Arikci D, Borgulya J, Straumann I, Vizeli P, Luethi D, Thomann J, Rudin D, Vukalovic I, Eckert A, Liechti ME, Holze F.   +10 more
europepmc   +1 more source

Antibiotic-induced Microbiome Depletion Selectively Reduces Baseline Hypothalamic Oxytocin Signaling without Affecting MDMA-induced Oxytocin Response in Rats. [PDF]

Clin Psychopharmacol Neurosci
Yue Y, Cai Y, Murayama R, Ding X, Wan X, Liu G, Hashimoto H, Anzai N, Hashimoto K.   +8 more
europepmc   +1 more source

MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model-informed analysis. [PDF]

CPT Pharmacometrics Syst Pharmacol
Huestis MA, Smith WB, Leonowens C, Blanchard R, Viaccoz A, Spargo E, Miner NB, Yazar-Klosinski B.   +7 more
europepmc   +1 more source